Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2022-07-26 00:00:00 ET · period of report 2022-07-22 · accession 0001209191-22-043221 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-07-26 | 2022-07-22 | RVMD | Schroeder Thilo | Dir | P - Purchase | $20.00 | +250.0K | 1.22M | +26% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-22 | P | A | 250,000 | $20.00 | 1,221,315 | I By Nextech Crossover I SCSP | — | — | (F1) Nextech Invest AG is the investment advisor of Nextech Crossover I SCSP ("Nextech Crossover"). The reporting person is a managing member at Nextech Invest AG and may therefore be deemed to be the beneficial owner of shares held by Nextech Crossover. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. |